Kaiser Permanente Ventures invests in early to growth stage healthcare companies that strategically align with Kaiser Permanente's mission. Their focus is on innovations in digital health, health IT, medical devices, and services that enhance care delivery, patient outcomes, and operational efficiency.
69% of their portfolio is in Healthcare. Deal activity increased 100% year-over-year (4 deals in the last 12 months). Average disclosed round size is $80.0M (across 48 rounds with reported amounts).
Portfolio
48
Fund Size
$500M
Top Stage
Series C
Last 12 Mo
4
Team
Daniel van den Bergh
Senior Investment Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
48 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Garner Health | Series D | $118M | Feb 2026 |
| SSureCo | Series A | $23M | Sep 2025 |
 Arine | Series C | $30M | Jun 2025 |
 Clarium | Series A | $27M | May 2025 |
 Innovaccer | Series F | $275M | Jan 2025 |
 Habitat Health | Series A | $50M | Sep 2024 |
 Everytable | Series C | $25M | Jun 2023 |
 DexCare | Series C | $75M | Jun 2023 |
 Incredible Health | Series B | $80M | Aug 2022 |
 Ordr | Series C | $40M | Jun 2022 |
 Zepto | Series D | $200M | May 2022 |
 IntelyCare | Series C | $115M | Apr 2022 |
 AnyRoad | Series B | $47M | Feb 2022 |
 Secureframe | Series B | $56M | Feb 2022 |
| DexCare | Series B | $50M | Jan 2022 |
| MMedically Home | Growth | $110M | Jan 2022 |
 Freenome | Series D | $300M | Dec 2021 |
| OOsso VR | Series B | $27M | Jul 2021 |
 Protenus | Series D | $21M | Jun 2021 |
 PathAI | Series C | $165M | May 2021 |
| DexCare | Series A | $20M | Mar 2021 |
| Everytable | Series B | $16M | Nov 2020 |
 Kate Farms | Series B | $51M | Nov 2020 |
| OOsso VR | Series A | $14M | Sep 2020 |
 Big Health | Series B | $39M | Jun 2020 |
Page 1 of 2
Top Co-Investors
Andreessen Horowitz6 shared
Providence Ventures6 shared
RA Capital Management4 shared
Polaris Venture Partners4 shared
Sands Capital4 shared
Transformation Capital4 shared
Perceptive Advisors3 shared
GV (Google Ventures)3 shared
Section 323 shared
Frist Cressey Ventures3 shared
SpringRock Ventures3 shared
Norwest Venture Partners3 shared
LionBird Ventures3 shared
F-Prime Capital3 shared
Janus Henderson Investors2 shared
Novartis Venture Fund2 shared
T. Rowe Price Associates, Inc.2 shared
Mayo Clinic2 shared
Oak HC/FT2 shared
Roche Venture Fund2 shared
Last updated: 15 April 2026